Conestat Alfa: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Conestat Alfa. Educational only — not medical advice.
Labeled uses
RUCONEST is a C1 esterase inhibitor [recombinant] indicated for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE). Limitation of Use: Effectiveness was not established in HAE patients with laryngeal attacks.
Source: FDA labeling via NIH DailyMed (set 66d3fecb…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.